SAT-194 - The safety and efficacy of hepalatide (L47) treatment combined with pegylated interferon-alpha 2a in patients with chronic hepatitis B: the preliminary data from a double-blind, RCT phase II trial
- Resource Type
- Abstract
- Source
- In
Journal of Hepatology June 2023 78 Supplement 1:S1166-S1167 - Subject
- Language
- ISSN
- 0168-8278